A Phase 1 Study to Further Investigate the Pharmacokinetics, Safety and Tolerability, Food Effect and Drug-Drug Interaction of LY4268989 (MORF-057) in Healthy Participants
Latest Information Update: 03 Jun 2025
At a glance
- Drugs MORF 057 (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 29 May 2025 Status changed from not yet recruiting to recruiting.
- 16 May 2025 New trial record